Search tool

Introduction The task of the Scientific Committee is to assist the Management Board and the Director of the EMCDDA by delivering an opinion on any scientific matter concerning the Centre's activity which the

Introduction The Management Board is the main decision-making body of the EMCDDA. It meets at least once a year and consists of one representative from each Member State of the European Union, Norway

Introduction Note: this page contains information about that a project that is now considered archived.
 
 The European expert network on drug use modelling was a project funded by the European Commission, DG Research, Targeted

Introduction The EMCDDA cooperates with candidate and potential candidate countries to the EU since 2008, by developing and implementing technical cooperation projects financed by the Instrument of Pre-accession Assistance (IPA) of the European

Introduction The EMCDDA cooperates with candidate and potential candidate countries to the EU since 2008, by developing and implementing technical cooperation projects financed by the Instrument of Pre-accession Assistance (IPA) of the European

Introduction The EMCDDA cooperates with candidate and potential candidate countries to the EU since 2008, by developing and implementing technical cooperation projects financed by the Instrument of Pre-accession Assistance (IPA) of the European

Introduction The EMCDDA cooperates with candidate and potential candidates to the EU since 2008, by developing and implementing technical cooperation projects financed by the Instrument for Pre-accession Assistance (IPA) of the European Commission. The

Introduction Source: European Drug Report 2019
 
 On 21-22 October 2019, the EMCDDA brings together more than fifty European and international experts for a meeting on the key indicator Drug-related deaths. The meeting provides

Introduction The 2019 annual expert meeting on the EMCDDA epidemiological indicator ‘Prevalence and patterns of drug use among the general population’ (often referred to as the 'General population surveys indicator') took place on

Introduction Elimination of viral hepatitis as a public health threat
 
 The introduction of direct-acting antiviral (DAA) therapy has profoundly changed and improved the clinical management of hepatitis C virus (HCV) infection and given